It has been demonstrated that upregulated VSIR on the tumor-infiltrating myeloid cells promotes tumor growth via suppressing T cell immunity [43], indicating that PXN might exhibit certain functions in immunotherapy for ovarian cancer. This evidence concerns the gene VSIR and ovarian carcinoma.